Brain Mets - Capecitabine Plus Sunitinib and WBRT

NCT00570908 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual this study is being closed to accrual

Conditions

Breast Cancer

Interventions

DRUG: sunitinib
DRUG: capecitabine
RADIATION: WBRT

Sponsor

Baylor Breast Care Center